Founded in 2017, Eremedium was built on the insight that patient comprehension directly influences confidence, adherence, and outcomes. In everyday clinical practice, even highly experienced doctors face challenges when explaining complex conditions or procedures within limited consultation time. This often leaves patients uncertain, anxious, or inadequately informed—particularly in superspecialty care, where decisions carry significant physical and emotional implications. Eremedium was created to address this gap by making medical communication clearer, more engaging, and easier to absorb.
“As healthcare becomes more specialised and time-constrained, visual communication will define the future of patient engagement,” said Mohanish Singh, CEO of Eremedium. “Our mission is to ensure that no patient leaves a consultation confused or uncertain about their care.”
Rather than positioning itself as a conventional HealthTech platform, Eremedium operates as a clinical communication partner. Its solutions are designed to integrate seamlessly into existing clinical workflows, allowing doctors to enhance patient understanding without increasing consultation time or disrupting care delivery. This approach has driven consistent adoption across geographies and specialties.
Today, Eremedium supports over 15,000 doctors across 25 medical specialties worldwide. Its platforms are used by clinicians in cardiology, orthopaedics, neurosurgery, urology, vascular surgery, and other complex disciplines where precise communication is essential. In such settings, visual explanations often prove far more effective than verbal descriptions alone, helping patients better understand anatomy, disease progression, and procedural steps.
Central to Eremedium’s growth is its integrated product ecosystem, which approaches patient education as a continuous journey rather than a single-point interaction. The company’s in-clinic patient education platform, Medio, is deployed across more than 10,000 healthcare waiting area TVs. By introducing visual explanations before patients meet their doctors, Medio helps establish foundational understanding, reduces anxiety, and prepares patients for more meaningful consultations.
Inside the consultation room, MedComm, a 22-inch touch screen solution, enables structured doctor–patient conversations. Used by thousands of clinicians, the platform helps ensure that condition, treatment options, risks, and recovery pathways are explained in a clear and consistent manner, while allowing doctors to retain their individual consultation style. Complementing this is MedXplain, Eremedium’s advanced 3D medical animation cloud-based platform, which supports counselling by over 9,000 doctors globally. These animations allow patients to visualise medical concepts that are otherwise difficult to grasp, significantly improving comprehension and recall.
Together, Medio, MedComm, and MedXplain form a layered communication framework that supports patient understanding from the waiting room through counselling. This structured approach helps reduce fear, improves clarity, and supports informed decision-making—key factors in modern, patient-centric healthcare.
While Eremedium’s roots are firmly in India, the relevance of its solutions has proven global. The company has expanded its presence across Asia, Africa, and Europe, with operations in Malaysia, Sri Lanka, South Africa, Ireland, and the United Kingdom. Planned entry into GCC markets reflects rising demand for digital health tools that prioritise patient experience and outcomes.
“Our mission has always been to simplify and strengthen communication between doctors and patients,” Ranjeet Sharma, VP, Eremedium noted. “Visual education is no longer optional—it is essential.”
As it continues to scale, Eremedium is investing in deeper clinical accuracy, richer specialty-specific content, and advanced visualisation technologies. Its journey reflects a broader truth shaping global healthcare today: better understanding leads to better outcomes. By placing communication at the centre of care, Eremedium is helping redefine how medicine is explained, understood, and trusted.
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
%20(1).jpg)
.jpg)
.jpg.jpeg)
